These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation. Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023 [TBL] [Abstract][Full Text] [Related]
66. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
67. In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents. Wakabayashi K; Mintz G; Delhaye C; Choi YJ; Doh JH; Ben-Dor I; Gaglia M; Pakala R; Suddath W; Satler L; Kent K; Pichard A; Weissman N; Waksman R J Invasive Cardiol; 2011 Jul; 23(7):262-8. PubMed ID: 21725119 [TBL] [Abstract][Full Text] [Related]
68. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. Hoffmann R; Jansen C; König A; Haager PK; Kerckhoff G; vom Dahl J; Klauss V; Hanrath P; Mudra H Eur Heart J; 2001 Nov; 22(21):2007-14. PubMed ID: 11603908 [TBL] [Abstract][Full Text] [Related]
69. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses. Sakata K; Waseda K; Kume T; Otake H; Nakatani D; Yock PG; Fitzgerald PJ; Honda Y Circ Cardiovasc Interv; 2012 Dec; 5(6):763-71. PubMed ID: 23149332 [TBL] [Abstract][Full Text] [Related]
70. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up. Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862 [TBL] [Abstract][Full Text] [Related]
71. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography. Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663 [TBL] [Abstract][Full Text] [Related]
72. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299 [TBL] [Abstract][Full Text] [Related]
73. Comparison of scanning electron microscopy and optical coherence tomography for imaging of coronary bifurcation stents. Silva GV; Gahremanpour A; Attizzani GF; Zeng Y; Wang W; Yamamoto H; Kanaya T; Rippy MK; Bezerra HG; Costa MA; Perin E Catheter Cardiovasc Interv; 2015 Jun; 85(7):1141-9. PubMed ID: 25044710 [TBL] [Abstract][Full Text] [Related]
74. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950 [TBL] [Abstract][Full Text] [Related]
75. Pathology of acute and chronic coronary stenting in humans. Farb A; Sangiorgi G; Carter AJ; Walley VM; Edwards WD; Schwartz RS; Virmani R Circulation; 1999 Jan 5-12; 99(1):44-52. PubMed ID: 9884378 [TBL] [Abstract][Full Text] [Related]
76. Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Ikeda N; Kubota S; Okazaki T; Hara H; Hiroi Y Catheter Cardiovasc Interv; 2016 Jun; 87(7):E268-74. PubMed ID: 26991798 [TBL] [Abstract][Full Text] [Related]
77. Influence of stent design and deployment technique on neointima formation and vascular remodeling. König A; Schiele TM; Rieber J; Theisen K; Mudra H; Klauss V Z Kardiol; 2002; 91 Suppl 3():98-102. PubMed ID: 12641022 [TBL] [Abstract][Full Text] [Related]
78. Intravascular imaging and histological correlates of medial and intimal calcification in peripheral artery disease. Jinnouchi H; Sato Y; Bhoite RR; Kuntz SH; Sakamoto A; Kutyna M; Torii S; Mori M; Kawakami R; Amoa FC; Kolodgie FD; Virmani R; Finn AV EuroIntervention; 2021 Oct; 17(8):e688-e698. PubMed ID: 33896763 [TBL] [Abstract][Full Text] [Related]
79. Reproducibility of neointima quantification with motorized intravascular ultrasound pullback in stented coronary arteries. Regar E; Werner F; Siebert U; Rieber J; Theisen K; Mudra H; Klauss V Am Heart J; 2000 Apr; 139(4):632-7. PubMed ID: 10740144 [TBL] [Abstract][Full Text] [Related]
80. Effect of preintervention plaque burden on subsequent intimal hyperplasia in stented coronary artery lesions. Shiran A; Weissman NJ; Leiboff B; Kent KM; Pichard A; Satler LF; Wu H; Leon MB; Mintz GS Am J Cardiol; 2000 Dec; 86(12):1318-21. PubMed ID: 11113405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]